The administration of recombinant human granulocyte colony-stimulating factor (G-CSF) as a treatment for severe bacterial infection may elevate a patient's absolute neutrophil count (ANC) to normal or close to normal range. The gene discussed is CSF3; the disease is bacterial infectious disease.